Skip to main content

Table 2 Characteristics of patients of the 4 nutrition groups categorized based on SGA

From: Exploring the malnutrition status and impact of total parenteral nutrition on the outcome of patients with advanced stage ovarian cancer

  Nourished (n = 202) Moderately malnourished (n = 115) Severely malnourished (n = 98) P value
Age (years, median, range) 50 (25–75) 54 (25–74) 45 (26–75) 0.2268
Surgical FIGO stage     0.0745
Stage 3 (n, %) 175 (86.6%) 98 (85.2%) 75 (76.5%)  
Stage 4 (n, %) 27 (13.4%) 17 (14.8%) 23 (23.5%)  
Histology     0.7059
Serous (n, %) 166 (82.2%) 89 (77.4%) 75 (76.5%)  
Endometrioid (n, %) 22 (10.9%) 15 (13.0%) 11 (11.2%)  
Mixed (n, %) 6 (3.0%) 5 (4.3%) 4 (4.1%)  
Clear cell (n, %) 5 (2.5%) 4 (3.5%) 2 (2.0%)  
Other (n, %) 3 (1.5%) 2 (1.7%) 5 (5.1%)  
Cytoreduction     0.0793
Optimal (n, %) 177 (87.6%) 97 (84.3%) 76 (77.6%)  
Sub-optimal (n, %) 25 (12.4%) 18 (15.7%) 22 (22.4%)  
Days to flatus (median, range) 7 (4–10) 7 (4–10) 6.5 (4–10) 0.7305
Days of hospitalization (median, range) 12 (5–20) 13 (5–20) 12.5 (5–20) 0.673
Serum albumin (g/L) (median, range) 4.9 (3–6) 3.3 (1–5.9) 2.45 (1–4.8) < 0.001
BMI at admission (median, range) 27.9 (16.1–40) 22.8 (16.1–39.6) 20.15 (16–29.3) < 0.001
BMI after surgery (median, range) 25.9 (15.2–35) 23.8 (15.2–30.9) 21.05 (16–26) < 0.001
NRI at admission (median, range) 100 (97.5–108) 92 (83.5–99.9) 80.15 (75.5–91.4) < 0.001
PFS (days, median, range) 108 (20–200) 90 (10–179) 67.5 (10–120) < 0.001
OS (days, median, range) 240.5 (102–396) 227 (100–357) 207.5 (983–298) < 0.001